Breaking News

Change of Management at The Romaco Group

Markus Kimpel appointed new Group CFO

Markus Kimpel has been appointed chief financial officer of the Romaco Group. He succeeds Carsten Strenger, who will be leaving the company at the end of 2019. 

Kimpel will also serve as managing director of Romaco Pharmatechnik GmbH, the manufacturing facility in Karlsruhe (Germany). He will be taking over both positions from Strenger. Kimpel will in future lead the international Romaco Group’s management team together with Romaco CEO Jörg Pieper. He will simultaneously work alongside Markus Regner as joint Managing Director of Romaco Pharmatechnik GmbH. Kimpel will have responsibility for Finance, Controlling, IT and Human Resources both as CFO and in his role as Managing Director of Romaco Pharmatechnik.
 
In the course of a career spanning nearly 25 years, Kimpel has accumulated extensive management experience in the construction and automotive supplies industries as well as in the engineering sector. A native of Frankfurt, he holds a degree in Business Administration & Mechanical Engineering and has served in various management positions including Managing Director, CFO, Director Finance and Interim Plant Manager. Most recently, he was Managing Director & CFO at the Aalen-based Alfing Special Machine Group as well as Group CFO at aluplast in Karlsruhe.
 
“We particularly value Markus Kimpel’s experience as a manager and as a proven financial specialist”, said Pieper. “With him on board the management team, we are optimally prepared for whatever commercial or processing challenges lie ahead of us. He will be a great asset for our company and a worthy successor to Carsten Strenger. I would like to take this opportunity to thank Mr. Strenger on behalf of everyone at Romaco for being such a great colleague to work with and wish him all the best for his professional future.”
Innovative change management
 
“I enjoy taking on new challenges”, said Kimpel. “Wrapping up the Romaco Group’s integration into Truking, the Chinese parent company, will call for a mix of commercial expertise and diplomatic skills. I am personally very much looking forward to this new, exciting assignment together with my team because I firmly believe this German-Sino constellation offers development and growth opportunities for all players.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters